Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Traws Pharma, Inc. Director's Dealing 2013

Jul 25, 2013

35199_dirs_2013-07-24_5a6866b8-21f6-479d-9085-99b1c24202c7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-24

Reporting Person: Michael & Jane Hoffman 2013 Descendants (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 644660 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Series B Convertible Preferred Stock $ Common Stock (99350) Direct
Series C Convertible Preferred Stock $ Common Stock (140449) Direct
Series D Convertible Preferred Stock $ Common Stock (355528) Direct
Series E Convertible Preferred Stock $ Common Stock (634625) Direct
Series F Convertible Preferred Stock $ Common Stock (111227) Direct
Series G Convertible Preferred Stock $ Common Stock (229825) Direct
Series H Convertible Preferred Stock $ Common Stock (301290) Direct
Series I Convertible Preferred Stock $ Common Stock (1635514) Direct

Footnotes

F1: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.85-for-1 basis and has no expiration date.

F2: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F3: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F4: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F5: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.77-for-1 basis and has no expiration date.

F6: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F7: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.

F8: The convertible preferred stock is convertible at any time, at the holder's election, and is automatically convertible immediately prior to the consummation of the Issuer's initial public offering on a 0.75-for-1 basis and has no expiration date.